Dachaigh › Myeloma iomaill smùidte
Sgrùdaidhean clionaigeach Myeloma iomaill smùidte a’ fastadh anns na SA
Tha 20 sgrùdaidhean airson Myeloma iomaill smùidte a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Boston, MA6 sgrùdaidhean
- New York City, NY6 sgrùdaidhean
- Atlanta, GA5 sgrùdaidhean
- Denver, CO3 sgrùdaidhean
- Durham, NC3 sgrùdaidhean
- Houston, TX3 sgrùdaidhean
- Columbus, OH3 sgrùdaidhean
- Salt Lake City, UT3 sgrùdaidhean
- Edison, NJ3 sgrùdaidhean
Le stàit
- Colorado3 sgrùdaidhean
- Florida4 sgrùdaidhean
- Georgia5 sgrùdaidhean
- Massachusetts6 sgrùdaidhean
- Michigan4 sgrùdaidhean
- New Jersey3 sgrùdaidhean
- New York8 sgrùdaidhean
- North Carolina4 sgrùdaidhean
- Ohio3 sgrùdaidhean
- Texas4 sgrùdaidhean
- Utah3 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06768489A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07393282Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT03937635Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Iuch 2026 · NCT05469893CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 30 agus nas sine · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT06644625A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06140524Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Ògmh 2026 · NCT04776395Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Cèit 2026 · NCT02269592FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Cèit 2026 · NCT07446777Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Gibl 2026 · NCT02726750A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT05640843Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT05136807Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Gibl 2026 · NCT05361694Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Gearr 2026 · NCT06212323Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dùbh 2025 · NCT05312255Registry for Adults With Plasma Cell Disorders (PCD's)
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Samh 2025 · NCT03717844A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Samh 2025 · NCT06055894The Indiana Myeloma Registry
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Samh 2025 · NCT03616483Screening for AL Amyloidosis in Smoldering Multiple Myeloma
A’ fastadhSgrùdadh amharc
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2025 · NCT06365060Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Gearr 2025 · NCT05597345Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.